No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr1:211771600-211786200 |
Weak transcription |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
2 |
chr1:211772200-211778000 |
Enhancers |
Placenta |
Placenta
|
3 |
chr1:211772600-211780600 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
4 |
chr1:211775200-211776400 |
Enhancers |
HepG2 |
liver
|
5 |
chr1:211775200-211776800 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
6 |
chr1:211775200-211777000 |
Enhancers |
Placenta Amnion |
Placenta Amnion
|
7 |
chr1:211775200-211777400 |
Enhancers |
NHDF-Ad |
bronchial
|
8 |
chr1:211775200-211777600 |
Enhancers |
Fetal Adrenal Gland |
Adrenal Gland
|
9 |
chr1:211775200-211778600 |
Enhancers |
Fetal Intestine Small |
intestine
|
10 |
chr1:211775400-211776200 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
11 |
chr1:211775400-211776400 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
12 |
chr1:211775400-211776400 |
Enhancers |
Stomach Mucosa |
stomach
|
13 |
chr1:211775400-211777000 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
14 |
chr1:211775400-211777000 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
15 |
chr1:211775400-211777000 |
Enhancers |
Hela-S3 |
cervix
|
16 |
chr1:211775400-211777400 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
17 |
chr1:211775400-211777400 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
18 |
chr1:211775400-211777600 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
19 |
chr1:211775400-211777600 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
20 |
chr1:211775400-211777600 |
Enhancers |
Duodenum Mucosa |
Duodenum
|
21 |
chr1:211775400-211777600 |
Enhancers |
HMEC |
breast
|
22 |
chr1:211775400-211777600 |
Enhancers |
NHEK |
skin
|
23 |
chr1:211775400-211778000 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
24 |
chr1:211775400-211778400 |
Enhancers |
Liver |
Liver
|
25 |
chr1:211775400-211778800 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
26 |
chr1:211775600-211776200 |
Enhancers |
Fetal Lung |
lung
|
27 |
chr1:211775600-211776200 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
28 |
chr1:211775600-211777000 |
Enhancers |
Adipose Nuclei |
Adipose
|
29 |
chr1:211775600-211777200 |
Enhancers |
NHLF |
lung
|
30 |
chr1:211775800-211776200 |
Weak transcription |
Fetal Intestine Large |
intestine
|
31 |
chr1:211775800-211776600 |
Weak transcription |
Rectal Mucosa Donor 31 |
rectum
|
32 |
chr1:211775800-211777200 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
33 |
chr1:211776000-211776600 |
Enhancers |
Small Intestine |
intestine
|
34 |
chr1:211776000-211776800 |
Weak transcription |
Esophagus |
oesophagus
|
35 |
chr1:211776000-211777000 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
36 |
chr1:211776000-211777000 |
Enhancers |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
37 |
chr1:211776000-211777200 |
Enhancers |
Osteobl |
bone
|
38 |
chr1:211776000-211777800 |
Enhancers |
K562 |
blood
|
39 |
chr1:211776000-211778400 |
Weak transcription |
GM12878-XiMat |
blood
|